Trials / Completed
CompletedNCT00380523
Analgesic Treatment Mediated by Arcoxia (0663-093)
Analgesic Treatment Mediated by Arcoxia
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 237 (estimated)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Allow physicians to test the efficacy of arcoxia in patients with acute pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0663, Arcoxia, etoricoxib / Duration of Treatment: 3 Days |
Timeline
- Start date
- 2005-04-01
- Primary completion
- 2005-05-01
- Completion
- 2005-05-01
- First posted
- 2006-09-26
- Last updated
- 2022-02-16
Source: ClinicalTrials.gov record NCT00380523. Inclusion in this directory is not an endorsement.